For SFTPA2, the expression was 0.2635 ± 0.1272 in asymptomatic COVID-19-positive individuals, 0.0271 ± 0.0035 in the mild group, and 1.3530 ± 0.7601 in severe cases. This evidence concerns the gene SFTPA2 and COVID-19.